Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$0.64 - $1.31 $48,330 - $98,927
-75,517 Reduced 35.17%
139,196 $121,000
Q3 2022

Nov 10, 2022

SELL
$0.8 - $1.65 $128,523 - $265,079
-160,654 Reduced 42.8%
214,713 $277,000
Q2 2022

Aug 10, 2022

BUY
$0.56 - $3.25 $209,615 - $1.22 Million
374,314 Added 35547.39%
375,367 $327,000
Q1 2022

May 12, 2022

SELL
$2.46 - $5.92 $4,698 - $11,307
-1,910 Reduced 64.46%
1,053 $3,000
Q4 2021

Feb 10, 2022

BUY
$4.26 - $23.33 $8,370 - $45,843
1,965 Added 196.89%
2,963 $15,000
Q3 2021

Nov 10, 2021

BUY
$18.12 - $28.5 $18,083 - $28,443
998 New
998 $24,000

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $53.9M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.